Psychedelic-Assisted Therapy Education
As PAT rapidly move toward clinical implementation, our aim is to develop educational programming for interdisciplinary clinicians with a focus on serious illness care. We are collaborating with PAT education leaders nationwide to ensure our programming complies with still-evolving standards of certification to practice PAT.
Our team is also dedicated to leading conversation in the academic space and broader community about psychedelic-assisted therapies and their role in the care of patients with cancer. We speak nationally and internationally about our work and psychedelic-assisted therapies more generally, and enjoy creatively presenting our findings, experiences, and ideas.
Learn more about our PAT education program, and also a list of selected speaking engagements.
Our team is also dedicated to leading conversation in the academic space and broader community about psychedelic-assisted therapies and their role in the care of patients with cancer. We speak nationally and internationally about our work and psychedelic-assisted therapies more generally, and enjoy creatively presenting our findings, experiences, and ideas.
Learn more about our PAT education program, and also a list of selected speaking engagements.
The Harvard Interdisciplinary Program in Psychedelics (HIPP)
In collaboration with the Multidisciplinary Association of Psychedelic Studies-Public Benefit Corporation, and our colleagues from the Massachusetts General Hospital Center for the Neuroscience of Psychedelics in Psychiatry, we are offering a new educational program for clinicians across disciplines to learn the foundations of psychedelic-assisted therapies across multiple indications and modalities. The curriculum includes a didactic series by Harvard faculty and researchers, experiential learning including a MDMA-assisted therapy for PTSD education event, and further community-building activities. Below are the flyers for the inaugural HIPP 2023-2024.
R. Sholevar 2023
|
R Sholevar 2023
|
This year's HIPP program cohort is closed. We will begin accepting applications for the 2024-2025 cohort in Summer 2024. To learn more, please contact Roxanne Sholevar, MD at [email protected]
Selected Speaking Engagements
Practical Considerations for Practicing Psychosocial Oncology in the World of Cannabis, Ketamine, and Psychedelic-Assisted Therapies
Workshop at the Academy of Consultation-Liaison Psychiatry Annual Meeting, November 2023
Roxanne Sholevar, MD; Ilana Braun, MD; Angela Landerholm, MD; John Peteet, MD; Carrie Wu, MD
Psychedelic-Assisted Therapies in Palliative Care
Practical Aspects of Palliative Care Course; Center for Palliative Care, Harvard Medical School, September 2023
Yvan Beaussant, MD, MSc; Roxanne Sholevar, MD
Pilot study of Psilocybin-Assisted Therapy in Hospice care (PATH): preliminary feasibility, safety and efficacy considerations. Clinical Trials stage; Psychedelic Science Conference, Denver CO, June 2023
Yvan Beaussant, MD, MSc; Roxanne Sholevar, MD; Lisa Summer PhD; Robin McKenna
Music and psychedelics. Paper presented at End of Life and Palliative Care Panel Workshop;
Psychedelic Science Conference, Denver CO June 2023
Yvan Beaussant, MD, MSc; Lisa Summer PhD
Acceptability of Group-Based Psilocybin-Assisted Therapy in Patients with Cancer and Major Depressive Disorder.
Lecture at the Breaking Convention Conference 2023
Yvan Beaussant, MD, MSc
Invited co-chair of the panel “Promoting Equity in Psychedelic Assisted Therapy in Serious Illness Care” at the 23rd McGill International Palliative Care Congress (MIPCC) in Montreal, October 2022
Yvan Beaussant, MD, MSc
Building a Framework for Existential Care: The intersection of Palliative Care and Psychedelic Research.
Invited presentation at the Memorial Sloan Kettering Cancer Center World Hospice and Palliative Care Day, October 2021
Yvan Beaussant, MD, MSc
Workshop at the Academy of Consultation-Liaison Psychiatry Annual Meeting, November 2023
Roxanne Sholevar, MD; Ilana Braun, MD; Angela Landerholm, MD; John Peteet, MD; Carrie Wu, MD
Psychedelic-Assisted Therapies in Palliative Care
Practical Aspects of Palliative Care Course; Center for Palliative Care, Harvard Medical School, September 2023
Yvan Beaussant, MD, MSc; Roxanne Sholevar, MD
Pilot study of Psilocybin-Assisted Therapy in Hospice care (PATH): preliminary feasibility, safety and efficacy considerations. Clinical Trials stage; Psychedelic Science Conference, Denver CO, June 2023
Yvan Beaussant, MD, MSc; Roxanne Sholevar, MD; Lisa Summer PhD; Robin McKenna
Music and psychedelics. Paper presented at End of Life and Palliative Care Panel Workshop;
Psychedelic Science Conference, Denver CO June 2023
Yvan Beaussant, MD, MSc; Lisa Summer PhD
Acceptability of Group-Based Psilocybin-Assisted Therapy in Patients with Cancer and Major Depressive Disorder.
Lecture at the Breaking Convention Conference 2023
Yvan Beaussant, MD, MSc
Invited co-chair of the panel “Promoting Equity in Psychedelic Assisted Therapy in Serious Illness Care” at the 23rd McGill International Palliative Care Congress (MIPCC) in Montreal, October 2022
Yvan Beaussant, MD, MSc
Building a Framework for Existential Care: The intersection of Palliative Care and Psychedelic Research.
Invited presentation at the Memorial Sloan Kettering Cancer Center World Hospice and Palliative Care Day, October 2021
Yvan Beaussant, MD, MSc
Additional Resources
[Coming Soon]
